Sutro Biopharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-180.64	-191.09	-227.46	-106.79	-119.2	-105.54
Depreciation & Amortization	6.06	7.32	7.22	6.82	5.69	4.84
Asset Writedown & Restructuring Costs	1.69	1.69	-	-	-	-
Loss (Gain) From Sale of Investments	-2.18	-3.44	-41.86	-18.99	-16.57	7.24
Stock-Based Compensation	6.78	14.01	24.69	24.91	26.3	23.24
Other Operating Activities	44.5	44.66	36.97	16.82	2.92	6.16
Change in Accounts Receivable	2.2	4.64	27.46	-28.96	5.34	-6.9
Change in Accounts Payable	-0.97	-2.47	0.71	4.81	-1.23	2.71
Change in Unearned Revenue	-12.41	-69.73	7.85	-32.6	93.65	-15.21
Change in Other Net Operating Assets	-10.2	17.16	-27.11	22.37	6.64	1.77
Operating Cash Flow	-145.17	-177.23	-191.54	-111.62	3.55	-81.68
Operating Cash Flow Growth	-	-	-	-	-	-
Capital Expenditures	-0.45	-1.7	-3.1	-4.32	-7.86	-15.32
Investment in Securities	33.23	46.71	221.61	0.39	-27.17	-82
Other Investing Activities	-	-	-	-	0.01	0.01
Investing Cash Flow	32.79	45.01	218.51	-3.92	-35.02	-97.32
Long-Term Debt Repaid	-	-	-4.08	-12.5	-9.38	-
Net Debt Issued (Repaid)	-	-	-4.08	-12.5	-9.38	-
Issuance of Common Stock	102.95	0.38	98.65	14.34	58.15	4.25
Repurchase of Common Stock	-0.25	-0.33	-0.51	-0.49	-0.46	-0.99
Other Financing Activities	-	-	-	136.21	-	-
Financing Cash Flow	102.7	0.04	94.05	137.55	48.31	3.26
Net Cash Flow	-9.69	-132.17	121.02	22.01	16.84	-175.74
Free Cash Flow	-145.62	-178.93	-194.64	-115.93	-4.31	-97
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Margin	-318.63%	-174.59%	-313.72%	-75.41%	-6.36%	-156.76%
Free Cash Flow Per Share	-12.47	-21.06	-25.16	-19.27	-0.85	-21.03
Levered Free Cash Flow	-100.76	-112.39	-78.99	-36.57	-41.16	-59.62
Unlevered Free Cash Flow	-74.77	-86.1	-59.57	-21.72	-36.53	-57.62
Cash Interest Paid	-	-	0.31	1.13	1.87	2.05
Cash Income Tax Paid	-	-0.08	17.52	0.38	-	0.1
Change in Working Capital	-21.39	-50.4	8.9	-34.38	104.41	-17.62

SEC Filings: 10-K · 10-Q